Expert Opinion on Therapeutic Patents, Volume 30, Issue 10 (2020)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Therapeutic Patents, Volume 30, Issue 10 (2020)

See all volumes and issues
Vol 34, 2024 Vol 33, 2023 Vol 32, 2022 Vol 31, 2021 Volume 30, 2020 Vol 29, 2019 Vol 28, 2018 Vol 27, 2017 Vol 26, 2016 Vol 25, 2015 Vol 24, 2014 Vol 23, 2013 Vol 22, 2012 Vol 21, 2011 Vol 20, 2010 Vol 19, 2009 Vol 18, 2008 Vol 17, 2007 Vol 16, 2006 Vol 15, 2005 Vol 14, 2004 Vol 13, 2003 Vol 12, 2002 Vol 11, 2001 Vol 10, 2000 Vol 9, 1999 Vol 8, 1998 Vol 7, 1997 Vol 6, 1996 Vol 5, 1995 Vol 4, 1994 Vol 3, 1993 Vol 2, 1992 Vol 1, 1991
Download citations Download PDFs Download issue

Patent Evaluation

Article
Bispecific anti-PD-L1/PD-1 antibodies for advanced solid tumors: a patent evaluation of US2019010232
Nemesio Villa-Ruano, Tayde Guerrero-González, Eduardo Gómez-Conde & Martin Perez-Santos
Pages: 723-727
Published online: 23 Aug 2020
AbstractforBispecific anti-PD-L1/PD-1 antibodies for advanced solid tumors: a patent evaluation of US2019010232 | Full Text | References | PDF (2.1 MB) | EPUB
  • 193 Views
  • 2 CrossRef citations
  • 0Altmetric

Review

GPR120 agonists for the treatment of diabetes: a patent review (2014 present)
Xuqing Zhang & Mark J. Macielag
Pages: 729-742
Published online: 30 Aug 2020
AbstractforGPR120 agonists for the treatment of diabetes: a patent review (2014 present) | Full Text | References | PDF (675.4 KB) | EPUB
  • 1177 Views
  • 11 CrossRef citations
  • 0Altmetric
N-Methyl-D-Aspartate (NMDA) receptor modulators: a patent review (2015-present)
Hazem Ahmed, Ahmed Haider & Simon M. Ametamey
Pages: 743-767
Published online: 14 Sep 2020
AbstractforN-Methyl-D-Aspartate (NMDA) receptor modulators: a patent review (2015-present) | Full Text | References | PDF (1.5 MB) | EPUB
  • 748 Views
  • 27 CrossRef citations
  • 0Altmetric
Xanthine oxidase inhibitors: patent landscape and clinical development (2015–2020)
Jatinder Vir Singh, Preet Mohinder Singh Bedi, Harbinder Singh & Sahil Sharma
Pages: 769-780
Published online: 14 Sep 2020
AbstractforXanthine oxidase inhibitors: patent landscape and clinical development (2015–2020) | Full Text | References | PDF (3 MB) | EPUB
  • 369 Views
  • 31 CrossRef citations
  • 0Altmetric
GLP-1R agonists for the treatment of obesity: a patent review (2015-present)
Chunxia Liu, Yuxing Zou & Hai Qian
Pages: 781-794
Published online: 11 Sep 2020
AbstractforGLP-1R agonists for the treatment of obesity: a patent review (2015-present) | Full Text | References | PDF (2.3 MB) | EPUB
  • 1048 Views
  • 10 CrossRef citations
  • 0Altmetric
Cyclin-dependent kinase 4/6 inhibitors for cancer therapy: a patent review (2015 – 2019)
Peng-Fei Wang, Han-Yue Qiu, Yun He & Hai-Liang Zhu
Pages: 795-805
Published online: 30 Sep 2020
AbstractforCyclin-dependent kinase 4/6 inhibitors for cancer therapy: a patent review (2015 – 2019) | Full Text | References | PDF (488 KB) | EPUB
  • 281 Views
  • 6 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Leucine-rich repeat kinase 2 (LRRK2) inhibitors for Parkinson’s disease: a patent review of the literature to date
Margaux Morez et al.
Review Article | Published online: 19 Jul 2024
A patent review of small molecule CDK4/6 inhibitors in the treatment of cancer: 2020–present
Xiaoling Huang et al.
Review Article | Published online: 17 Jul 2024
Progress with polo-like kinase (PLK) inhibitors: a patent review (2018–present)
Shirong Bian et al.
Review Article | Published online: 15 Jul 2024
The therapeutic potential of phosphodiesterase 9 (PDE9) inhibitors: a patent review (2018-present)
Chen Zhang et al.
Review Article | Published online: 9 Jul 2024
View all latest articles